Jordan vs Russian Federation: Average cost of tuberculosis treatment by type
Jordan
20 constant 2022 US$
in 2024
Russian Federation
20 constant 2022 US$
in 2024
Jordan rank
26th
Russian Federation rank
26th
Average cost of tuberculosis treatment by type over time
- Jordan
- Russian Federation
How they compare
Jordan currently reports 20 constant 2022 US$ against 20 constant 2022 US$ in Russian Federation, a difference of 0 constant 2022 US$.
The two have swapped places 1 time across 5 shared years of data; in 2019 it was Jordan ahead.
Jordan ranks 26th and Russian Federation ranks 26th of 62 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20,000 constant 2022 US$ | 17 constant 2022 US$ | 19,983 constant 2022 US$ | Jordan |
| 2020s | 77.5 constant 2022 US$ | 18 constant 2022 US$ | 59.5 constant 2022 US$ | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Jordan or Russian Federation?
- Jordan, at 20 constant 2022 US$ against 20 constant 2022 US$ in Russian Federation as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Jordan and Russian Federation?
- 0 constant 2022 US$, with Jordan ahead.
- How many years of comparable data are there for Jordan and Russian Federation?
- 5 years are reported by both, from 2019 to 2024.
- How do Jordan and Russian Federation rank globally for average cost of tuberculosis treatment by type?
- Jordan ranks 26th and Russian Federation ranks 26th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.